Top 50 Biotechnology VC Funds in Italy
A list of 50 VC funds that invest in Biotechnology startups based in Italy. We rank investors based on the number of investments they made in Biotechnology companies from Italy. We update this investor list every month.Top 50 Biotechnology VC Funds in Italy
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Seed, Angel, Series A
- Italy, United States, United Kingdom
Portfolio highlights
- ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
- Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
- Clearbox AI — Benefit from Synthetic Data to unlock your AI projects, overcome privacy issues and improve the utility of your data.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Italy, Switzerland, United States
Portfolio highlights
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- MicThera — MicThera focuses on developing microbial-derived therapeutics to provide effective treatments for prostate cancer patients, aiming to find effective solutions for medical companies.
- Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more
Investment focus
- Software, E-Commerce, Computer
- Seed, Funding Round, Series A
- Italy, United States
Portfolio highlights
- Aindo — Unlock the full potential of your data. The power of synthetic data integrated in a comprehensive Data Platform.
- Coverzen — The digital office of insurers
- Starting Finance — Starting Finance is a financial education platform intended to provide financial literacy to its users. The company's platform provides education and information about finance and publishes informative articles on important events in the fields of economics, finance, and politics, enabling users to improve their knowledge regarding finance andthe management of their capital.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Funding Round, Series A, Seed
- Italy, United States, United Kingdom
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more
Investment focus
- Health Care, Medical, Medical Device
- Funding Round, Series A, Series B
- Italy, United States, Spain
Portfolio highlights
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Italy, United Kingdom, France
Portfolio highlights
- Touch Sensity — Touch Sensity is an information technology company that specializes in the fields of IoT and sensors.
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
- Evergreen Theragnostics — Increasing access to treatment and diagnostic options through radiopharmaceuticals
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more
Investment focus
- Software, Biotechnology, Hardware
- Funding Round, Seed, Series A
- Italy, United States, Israel
Portfolio highlights
- treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi:
scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more
Investment focus
- Biotechnology, Medical Device, Health Care
- Seed, Pre-Seed, Series A
- Italy, United States
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more
Investment focus
- Health Care, Biotechnology, Manufacturing
- Funding Round, Seed, Series A
- Italy, United Kingdom
Portfolio highlights
- Cogisen — Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy.
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation.
Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more
Investment focus
- Software, Medical, Health Care
- Series A, Funding Round, Seed
- Italy, United States, United Kingdom
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more
Investment focus
- Nanotechnology, Renewable Energy, Medical Device
- Funding Round, Seed, Pre-Seed
- Italy
Portfolio highlights
- Planckian — Charging the future by powering energy with science We explore frontiers of energy science by developing quantum...
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
- BeDimensional — We produce graphene and others two-dimensional materials (2D) with few atomic layers. Find out more.
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Funding Round
- Italy, United States, Germany
Portfolio highlights
- Loquis — La prima piattaforma per ascoltare e raccontare il mondo tramite podcast geolocalizzati
- Axelera AI — To accelerate computer vision in edge devices, we offer a powerful, energy-efficient, cost-effective, user-friendly AI hardware and software platform.
- Starting Finance — Starting Finance is a financial education platform intended to provide financial literacy to its users. The company's platform provides education and information about finance and publishes informative articles on important events in the fields of economics, finance, and politics, enabling users to improve their knowledge regarding finance andthe management of their capital.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more
Investment focus
- E-Commerce, Health Care, Software
- Seed, Series A, Funding Round
- Italy, United Kingdom, Israel
Portfolio highlights
- Glaut — Glaut is an AI-native customer survey platform that conducts in-depth, AI-moderated interviews with customers at scale.
- Algor Education — Algor Lab is a company that provides tools and materials needed for teaching through artificial intelligence.
- ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Seed, Series A, Series B
- Italy, United Kingdom
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
- Repron Therapeutics — Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely.
Angel group focuses on biotech
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- Italy
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
- Health Care, Wellness, Medical
- Seed, Funding Round, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Pear Suite — Pear Suite empowers community health workers with technology, education, and community, helping them do their best work and serve their communities.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers.
Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more
Investment focus
- Medical, Health Care, Privacy
- Seed, Angel, Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Seed, Pre-Seed, Grant
- Italy, United Kingdom
Portfolio highlights
Investment fund specialized in sustainable technologies from universities and public research organizations, start-ups, spin-offs, and entrepreneurs.
Show more
Investment focus
- Water, Eyewear, Farming
- Seed, Series A, Pre-Seed
- Italy, Ireland
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
- Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
- HT Materials Science — HT Materials Science provides nanofluid science in thermal systems for commercial and industrial infrastructure.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more
Investment focus
- Biotechnology, Therapeutics, Medical
- Series B, Series A, Funding Round
- United States, Italy, United Kingdom
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, The Netherlands
Portfolio highlights
- Rohlik — Rohlik is an innovative grocery delivery startup that offers a 90-minute same-day delivery service. Since its inception, Rohlik has been growing and is on track to EUR 300 mil. revenues in 2020. Rohlík was founded in 2014 by Marek Sacha and Tomas Cupr and is headquartered in Karlín, Hlavni mesto Praha, Czech Republic.
- Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
- ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more
Investment focus
- Software, Health Care, Medical
- Grant, Seed, Series A
- United States, China, Italy
Portfolio highlights
- DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
- Preteckt — Preteckt's AI software predicts & prevents breakdowns in buses & coaches. Reduce costs, maximize uptime, & extend vehicle life
- Branch Technology — Patented 3D-printed fabrication technology combining additive manufacturing, prefabrication, and digital technology at construction scale, with true design freedom.
VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Series C
- Switzerland, Germany, United States
Portfolio highlights
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
- Unique — Try Unique Finance GPT to increase productivity by automating manual workload through AI and ChatGPT solutions.
UniCredit Group is an Italian global banking and financial services company. Its network spanning 50 markets in 20 countries, with more than 9,000 branches and over 148,000 employees. Its strategic position in Western and Eastern Europe gives the group one of the region's highest market shares.
Show more
Investment focus
- Energy, Software, Financial Services
- Debt Financing, Post-IPO Debt, Funding Round
- Italy, Germany, Sweden
Portfolio highlights
- 3Sun — Our photovoltaic solutions drive change towards a sustainable future, setting new standards of excellence for solar energy applications.
- Goglio Group — Goglio Group produces full trademark food packaging.
- Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Series B, Series C
- United States, United Kingdom, Switzerland
Portfolio highlights
- Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
- Gynesonics — Gynesonics is a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions. Gynesonics serves customers worldwide. It was founded in 2005 and is headquartered in Redwood City, California.
- Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
Utopia is a venture capital firm that is dedicated to life sciences.Utopia SIS is an investment company specializing in healthcare and biomedical research, promoted and owned by the Golinelli Foundation.Utopia was established with the aim of bridging this gap, through investments in high-potential start-ups operating in the Life Sciencessector.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- Italy
Portfolio highlights
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, China, Italy
Portfolio highlights
- Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
- Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
- AmbAgon Therapeutics — AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
European Circular Bioeconomy Fund invest and partner with entrepreneurs to accelerate late-stage circular bioeconomy companies.
Show more
Investment focus
- Biotechnology, AgTech, Agriculture
- Series B, Series A, Series C
- The Netherlands, France, Italy
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
- watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
- RED Horticulture — RED Horticulture specializes in horticulture LED lighting systems, photobiology research, and indoor and greenhouse lighting.
3LB Seed Capital is not an alternative to start-ups incubators and accelerators, rather acts as a complementary reality that helps to enhance your project in terms of attractiveness for the investor and venture capital market.As investors they are the first willing to know if your project has what it takes to grow successfully. If they areconvinced of your potential, they are ready to bet on you, by joining you and helping you to develop your project.3LB Seed Capital does not provide a percentage of equity in exchange for accompanying activities, but relies exclusively on a premium at the time of its first direct investment in your company.
Show more
Investment focus
- E-Commerce, Information Technology, B2B
- Seed
- Italy
Portfolio highlights
- Vikey — Self check-in Automatico e Domotica per Gestire da Remoto ogni aspetto dell'accoglienza in Hotel, Case Vacanze, Appartamenti e B&B.
- YoAgents — YoAgents is a Digital Service company that allows sales professionals to connect with startups and micro-companies and SMEs.Through the app, they can choose services, pitch themselves to companies, download sales documents, create deals, with companies in the fitness, ho.re.ca., retail, sectors, as well as visualize and require revenue. Theplatform currently hosts over 2,000 sales professionals in its lead generation door to door platform.It was founded in 2016 and is headquartered in Milan, Italy.
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Riso Gallo is a rice producer specializing in processing, and distributing of risotto rice to consumers around the world.
Show more
Investment focus
- Biotechnology, Interior Design
- Funding Round
- Italy
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more
Investment focus
- Software, E-Commerce, Internet
- Series A, Series B, Seed
- United States, United Kingdom, France
Portfolio highlights
- Hedra — Video creation for everyone.
- Bridge — An entirely new payments platform, built with stablecoins, to simplify global money movement.
- Savvy Wealth — Savvy is the next-generation wealth management firm that pairs world-class advisors with modern software to help clients achieve their financial goals.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
- Navigator Medicines — Leading the advancement of biologics for targeted immune regulation & restoration.
- Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Schia Ventures is investment firm.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
Estor is a Investment Firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Seed
- Italy
Portfolio highlights
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
Lombardstreet Ventures operates as a pre-seed venture capital firm. It draws from talents around the world and fosters the creation of Silicon Valley Realities.The company consists of a team of seasoned executives works hand in hand with a small group of highly selected entrepreneurs. Expertise in funding and guidance is offered, to ensure thecreation of successful companies in the US.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Italy
Portfolio highlights
- Atopile — Atopile develops tools for crafting electronic circuit board designs using code. By replacing the traditional point-and-click schematic interface with code, they bring software development methodologies such as reuse, validation, and automation into the realm of electronics.
- RetailReady — Streamline retail compliance with directed workflows that require no training or integrations, eliminating paper SOPs and spreadsheet tracking. RetailReady has solutions for all stakeholders - brands, retailers, and 3PLs with a unified, automated approach. Backed by Y Combinator.
- K-Scale Labs — K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots.
DEEP BLUE VENTURES
Venture Capital Fund
DEEP BLUE VENTURES
DBV Deep Blue Ventures is our first Venture Capital fund
DBV is an early stage deep tech fund, investing in outstanding deep technologies, and people able to harnessing them to great global success.
Deep Blue Ventures
Show more
Investment focus
- Biotechnology, Medical Device, Artificial Intelligence
- Seed
- Italy
Portfolio highlights
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
Kering Ventures is the venture investment arm of the Kering Group, acquiring minority holdings in startups.
Show more
Investment focus
- Biotechnology, Interior Design
- Series A
- Italy
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Italy
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more
Investment focus
- Information Technology, Health Care, Mobile
- Seed, Funding Round, Pre-Seed
- Italy, Switzerland, United Kingdom
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the Metaverse for the mass market: virtual worlds, adventures, gaming Play & Earn and amazing experiences.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, United Kingdom, Canada
Portfolio highlights
- Disc Medicine — Disc Medicine is led by an experienced team of scientists and industry experts, and supported by a panel of advisors with a strong track record of discovering and developing new and innovative therapies. Disc Medicine was founded by Atlas Venture and Brian MacDonald, with Novo Ventures and Access Biotechnology joining as additional investors.
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
- GRO Biosciences — GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency,stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders, and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
Angels4Women is a company that invests in business startups lead by females.
Show more
Investment focus
- Retail, Fashion, Lingerie
- Seed, Angel, Funding Round
- Italy, United States
Portfolio highlights
- Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
- FUTURELY — FUTURELY is a platform which will help to choose university.
- Chite Milano — Lingerie the Italian way. Discover 100% Made in Italy lingerie. Make your own: customise your lingerie and nightwear.
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Funding Round
- United States, Italy, Canada
Portfolio highlights
- DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
- Inversago Pharma — Inversago Pharma is a preclinical-stage, biotech company specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists.
- Code Biotherapeutics — Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more
Investment focus
- Medical, Aerospace, Biotechnology
- Seed, Private Equity
- Italy, United Kingdom
Portfolio highlights
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- QuantaBrain — QuantaBrain purpose is to accelerate the diagnosis of psychiatric and neurodevelopmental diseases by applying artificial intelligence.
- Fluid Wire Robotics — Fluid Wire Robotics sets the new standard for robots in harsh environments. We design innovative robotic arms that excel in radioactive, explosive, space, and subsea applications, avoiding the complexity and cost of traditional solutions. Our technology ensures unparalleled safety, reliability, and efficiency, redefining robot design for any challenging environment without performance loss. Discover our groundbreaking approach and robust, versatile solutions.
Finalca is an Investment Company.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Italy
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Crédit Agricole Italia is a bank that offers loans and financial services.
Show more
Investment focus
- Water, Farming, Software
- Debt Financing, Seed
- Italy
Portfolio highlights
- Ecopol — The Ecopol's PVA water-soluble film technology is the world leading solution in packaging applications, such as detergents, agrochemicals, etc.
- Finapp — Finapp is an innovative startup that produces a new generation of CRNS probes that allow measuring the water content. Water in the ground, then soil moisture, water out of the ground, then in the biomass, water in the snow, then snow water equivalent. The applications are really many, such as the research of water losses along aqueducts,hydrological and hydraulic modeling, estimates of hydroelectric energy but mainly agricultural ones.
- Generalfinance — Generalfinance is a financial management agency that provides flexible services designed to address the company's debt issues.
F3F
Show more
Investment focus
- Hardware, Hospital, Software
- Series A, Series C
- Italy
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
RECOMEC operates as a venture capital firm that primarily invests in the healthcare sector.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more
Investment focus
- Software, Information Technology, Health Care
- Grant, Seed, Funding Round
- Spain, France, United Kingdom
Portfolio highlights
- Forkbomb — Cryptography, blockchain interoperability, digital identity
- Compellio — Manage the lifecycle of assets in the physical world through the use of digital twins on blockchains
- City and Me — City and Me is a digital response to the citizens' needs to communicate, be active, and act sustainably in their communities.
Arieli Capital is an investment firm dedicated to advancing cutting-edge technology by making strategic investments in top tech sectors
Show more
Investment focus
- Analytics, Biotechnology, Manufacturing
- Seed
- Italy, Israel
Portfolio highlights
- Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
- Terrific — We bring Brands & Influencers together to recreate the online shopping experience by empowering the story of your brand.
Investors by industry
Google
Artificial intelligence
Biotech
Climate
Proptech
Consumer
Media (entertainment)
Hardware
Community
Health Care
FinTech
EdTech
Sustainability
Gaming
Agriculture (agtech)
Venture Capital
Impact
Retail
Fashion
Beauty
Infrastructure
Marketplace
Big Data
Publishing
Energy
Food and Beverage
Art
Organic Food
Real Estate
Email
Photography
Social Media
B2B
Wellness
Web3
Oil and Gas
Social Network
Video Games
Medical
Financial Services
Finance
Manufacturing
Clean Energy
Payments
Internet
Education
Music
Fitness
Travel
Digital Media
Hospitality
Legal
Recruiting
Biotechnology
Franchise
Mobile Advertising
eSports
Cannabis
Local
Platforms
Android
Social
Crowdfunding
Construction
Automotive
Wine And Spirits
Medical Device
Enterprise Software
CleanTech
Mobile
Transportation
Mobile Apps
Sports
Enterprise
InsurTech
Renewable Energy
LGBT
Film
Theatre
Life Science
Non Profit
SaaS
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Facebook
Cryptocurrency
Blockchain
Investors by country
Germany
India
South Korea
Canada
New Zealand
Australia
United Kingdom
United States
Ireland
Japan
Armenia
Brazil
Africa
LATAM
Middle East
Asia
Saudi Arabia
Belize
Europe
Bahrain
Algeria
Barbados
Hungary
Gibraltar
Singapore
Costa Rica
Ethiopia
Greece
Spain
Finland
Estonia
Ghana
Vietnam
Ecuador
Chile
Egypt
China
Croatia
Georgia
Oceania
Belarus
Faroe Islands
Denmark
Hong Kong
Indonesia
France
Belgium
Qatar
South Africa
Bermuda
Bulgaria
Czech Republic
Sri Lanka
Kuwait
Lithuania
Tanzania
Mali
Philippines
Jersey
Myanmar
Malta
Mauritius
Nicaragua
Zimbabwe
Italy
Slovenia
Liechtenstein
Kenya
Tunisia
Cayman Islands
Russian Federation
Israel
Liberia
Panama
San Marino
Ukraine
Malaysia
Lebanon
Kazakhstan
Norway
Cambodia
Serbia
Morocco
Peru
Venezuela
Mexico
Thailand
Dominican Republic
Azerbaijan
Namibia
Nigeria
Zambia
Uzbekistan
Iraq
Iceland
Togo
Uruguay
Bahamas
United Arab Emirates
Tajikistan
Senegal
Honduras
Isle of Man
Bolivia
El Salvador
Luxembourg
Portugal
Albania
Pakistan
Sierra Leone
Turkey
Poland
Puerto Rico
Bangladesh
Romania
Taiwan
Grenada
Jordan
Argentina
Seychelles
Uganda
Rwanda
Sweden
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Marshall Islands
Colombia
Guatemala
VC Funds in Italy by industry
Restaurants
Media (entertainment)
Transportation
Financial Services
Food and Beverage
Venture Capital
Cryptocurrency
Education
Finance
Big Data
Payments
Wine And Spirits
Organic Food
Medical
Medical Device
Internet
Agriculture (agtech)
Social Media
Wellness
Manufacturing
Social Network
Art
Digital Media
Android
Mobile
Blockchain
Music
Construction
Local
Software
Sports
Enterprise Software
Travel
CleanTech
Automotive
InsurTech
Hospitality
Platforms
Recruiting
FinTech
Biotechnology
Enterprise
Health Care
Consumer
Biotech
Energy
Climate
EdTech
Sustainability
Impact
Proptech
Marketplace
Community
Hardware
Artificial intelligence
Gaming
Mobile Apps
Fashion
Retail
Social
Beauty
Web3
Life Science
B2B
Social Impact
Publishing
Real Estate
Renewable Energy
Fitness
SaaS
Oil and Gas